ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 249 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $428 | +415.7% | 29,656 | +140.7% | 0.00% | – |
Q2 2023 | $83 | -23.9% | 12,322 | 0.0% | 0.00% | -100.0% |
Q1 2023 | $109 | +16.0% | 12,322 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $94 | -99.9% | 12,322 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $88,000 | -12.0% | 12,322 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $100,000 | -41.5% | 12,322 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $171,000 | -50.6% | 12,322 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $346,000 | -17.4% | 12,322 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $419,000 | -16.7% | 12,322 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $503,000 | +1.4% | 12,322 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $496,000 | -32.0% | 12,322 | 0.0% | 0.00% | -50.0% |
Q4 2020 | $729,000 | +21.7% | 12,322 | 0.0% | 0.00% | +33.3% |
Q3 2020 | $599,000 | +0.5% | 12,322 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $596,000 | – | 12,322 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 3,030,434 | $20,334,212 | 13.72% |
BERYLSON CAPITAL PARTNERS, LLC | 228,000 | $1,529,880 | 4.32% |
Eagle Health Investments LP | 1,214,860 | $8,151,711 | 1.52% |
Matrix Capital Management Company, LP | 11,572,590 | $77,652,079 | 0.90% |
Triatomic Management LP | 121,166 | $813,024 | 0.83% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $201,257,781 | 0.82% |
Aristotle Atlantic Partners, LLC | 3,104,961 | $20,834,288 | 0.78% |
Pier Capital, LLC | 737,589 | $4,949,222 | 0.71% |
ARK Investment Management | 10,453,752 | $70,144,675 | 0.46% |
Nikko Asset Management Americas, Inc. | 6,384,047 | $42,773,115 | 0.45% |